This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
StarTek (SRT) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
StarTek (SRT) delivered earnings and revenue surprises of 85.71% and 4.55%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Should Value Investors Buy Barrett Business Services (BBSI) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Atento (ATTO) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Atento (ATTO) delivered earnings and revenue surprises of 13.33% and 1.71%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com featured highlights include UFP Industries, MEDIFAST, Skyline, Hudson Global and Expeditors International of Washington
by Zacks Equity Research
UFP Industries, MEDIFAST, Skyline, Hudson Global and Expeditors International of Washington are part of Zacks Screen of the Week article.
Is Brink's (BCO) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Explore DuPont Analysis & Pick 5 Top Stocks
by Sanghamitra Saha
Do you have more faith in DuPont analysis than simple ROE calculation? Tap UFP Industries (UFPI), MEDIFAST (MED), Skyline (SKY), Hudson Global (HSON) and Expeditors International of Washington (EXPD).
Dive Into DuPont Analysis & Pick 5 Top Stocks
by Sanghamitra Saha
Do you have more faith in DuPont analysis than simple ROE calculation? Tap Sanderson Farms (SAFM), MEDIFAST (MED), Skyline (SKY), Hudson Global (HSON) and Expeditors International of Washington (EXPD).
Is Harte Hanks (HHS) Stock Outpacing Its Business Services Peers This Year?
by Zacks Equity Research
Here is how Harte-Hanks (HHS) and Hudson Global (HSON) have performed compared to their sector so far this year.
HSON or EXLS: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
HSON vs. EXLS: Which Stock Is the Better Value Option?
Zacks.com featured highlights Sanderson Farms, MEDIFAST, Skyline, Hudson Global and Expeditors International of Washington
by Zacks Equity Research
Sanderson Farms, MEDIFAST, Skyline, Hudson Global and Expeditors International of Washington have been highlighted in this Screen of the Week article.
Dive Into DuPont Analysis & Pick 5 Top Stocks
by Sanghamitra Saha
Do you have more faith in DuPont analysis than simple ROE calculation? Tap Sanderson Farms (SAFM), MEDIFAST (MED), Skyline (SKY), Hudson Global (HSON) and Expeditors International of Washington (EXPD).
Is ABM Industries (ABM) Stock Outpacing Its Business Services Peers This Year?
by Zacks Equity Research
Here is how ABM Industries (ABM) and Hudson Global (HSON) have performed compared to their sector so far this year.
HSON vs. ADP: Which Stock Is the Better Value Option?
by Zacks Equity Research
HSON vs. ADP: Which Stock Is the Better Value Option?
Is Harte Hanks (HHS) Outperforming Other Business Services Stocks This Year?
by Zacks Equity Research
Here is how Harte-Hanks (HHS) and Hudson Global (HSON) have performed compared to their sector so far this year.
The Zacks Analyst Blog Highlights Avnet, Cross Country Healthcare, Hudson Global and Tenaris
by Zacks Equity Research
Avnet, Cross Country Healthcare, Hudson Global and Tenaris have been included in this Analyst Blog.
What Is a Safe Stock?
by Sejuti Banerjea
Inflation is atop everyone's mind as the Fed readies for a 50 (or 75, or...?) basis-point increase in the Fed funds interest rate.
Has Harte Hanks (HHS) Outpaced Other Business Services Stocks This Year?
by Zacks Equity Research
Here is how Harte-Hanks (HHS) and Hudson Global (HSON) have performed compared to their sector so far this year.
Earnings Estimates Moving Higher for Hudson Global (HSON): Time to Buy?
by Zacks Equity Research
Hudson Global (HSON) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Has Hudson Global (HSON) Outpaced Other Business Services Stocks This Year?
by Zacks Equity Research
Here is how Hudson Global (HSON) and Huron Consulting (HURN) have performed compared to their sector so far this year.
HSON vs. ADP: Which Stock Is the Better Value Option?
by Zacks Equity Research
HSON vs. ADP: Which Stock Is the Better Value Option?
Hudson Global (HSON) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Hudson Global (HSON) delivered earnings and revenue surprises of 173.33% and 9.30%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Best Growth Stocks to Buy for May 6th
by Zacks Equity Research
HSON, HCCI, and DVN made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 6, 2022.
Genpact (G) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Genpact (G) delivered earnings and revenue surprises of 13.21% and 3.65%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Strength Seen in Hudson Global (HSON): Can Its 11.4% Jump Turn into More Strength?
by Zacks Equity Research
Hudson Global (HSON) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Hudson Global (HSON) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Hudson Global (HSON) delivered earnings and revenue surprises of 121.74% and 8.24%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?